What does Docteur Xavier NéLISSEN do?

Docteur Xavier NéLISSEN is a specialist medical practice in Juprelle. Private Limited, started on 10 October 2005, 2 establishments.

What is the address of Docteur Xavier NéLISSEN?

The registered office of Docteur Xavier NéLISSEN is located at Rue Lambert Tilkin 2, 4453 Juprelle.

Is Docteur Xavier NéLISSEN still active?

Yes. According to the CBE (29 October 2026) Docteur Xavier NéLISSEN is active, legal situation “Normale toestand”, started on 10 October 2005.

Is Docteur Xavier NéLISSEN registered on Peppol?

Yes, Docteur Xavier NéLISSEN is registered on the Peppol network with ID 0208:0876586525.

What is the enterprise number of Docteur Xavier NéLISSEN?

The enterprise number of Docteur Xavier NéLISSEN is BE0876586525.

When was Docteur Xavier NéLISSEN founded?

Docteur Xavier NéLISSEN was founded on 10 October 2005.

Who are the directors of Docteur Xavier NéLISSEN?

According to the 2025 annual accounts, the directors of Docteur Xavier NéLISSEN are: Xavier Nélissen.

Is Docteur Xavier NéLISSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 October 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Docteur Xavier NéLISSEN make in 2025?

Docteur Xavier NéLISSEN posted a profit after taxes of € 95,729 in financial year 2025.

What is the revenue of Docteur Xavier NéLISSEN?

As a small company, Docteur Xavier NéLISSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 342,168.

How many employees does Docteur Xavier NéLISSEN have?

According to the 2025 annual accounts, Docteur Xavier NéLISSEN has 0.8 full-time equivalents (FTE).

Docteur Xavier NéLISSEN (Private Limited) - Juprelle

Dossier Docteur Xavier NéLISSEN, printed on 29 October 2026 from databakkes.be/en/0876586525/docteur-xavier-nelissen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 59 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Docteur Xavier NéLISSEN from Juprelle, company number BE0876586525, closed financial year 2025 with a result of € 95,729 after tax. For that financial year Docteur Xavier NéLISSEN recorded a gross margin of € 342,168 and equity of € 530,239. Compared with financial year 2024, the result moved from € 63,160 to € 95,729. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 530,239

▲ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 95,729

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,592

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 517,839.

People and assets in 2025

Full-time equivalents

0.8

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 67,048

▲ 2% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 42,230

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 503,683

▼ 39% vs 2024

€ 135,799 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 825

▼ 96% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 39,796

▼ 48% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 383,183 Gross margin 2022: € 383,183 First fiscal year in the series	€ 314,097 Gross margin 2023: € 314,097 ▼ 18% vs 2022 (€ 383,183) Unfavourable step	€ 321,174 Gross margin 2024: € 321,174 ▲ 2% vs 2023 (€ 314,097) Favourable step	€ 342,168 Gross margin 2025: € 342,168 ▲ 7% vs 2024 (€ 321,174) Favourable step	▲ 7%
Profit after taxes	€ 121,103 Profit after taxes 2022: € 121,103 First fiscal year in the series	€ 133,546 Profit after taxes 2023: € 133,546 ▲ 10% vs 2022 (€ 121,103) Favourable step	€ 63,160 Profit after taxes 2024: € 63,160 ▼ 53% vs 2023 (€ 133,546) Unfavourable step	€ 95,729 Profit after taxes 2025: € 95,729 ▲ 52% vs 2024 (€ 63,160) Favourable step	▲ 52%
Equity	€ 757,935 Equity 2022: € 757,935 First fiscal year in the series	€ 891,481 Equity 2023: € 891,481 ▲ 18% vs 2022 (€ 757,935) Favourable step	€ 434,510 Equity 2024: € 434,510 ▼ 51% vs 2023 (€ 891,481) Unfavourable step	€ 530,239 Equity 2025: € 530,239 ▲ 22% vs 2024 (€ 434,510) Favourable step	▲ 22%
Total debts	€ 1,013,538 Total debts 2022: € 1,013,538 First fiscal year in the series	€ 892,588 Total debts 2023: € 892,588 ▼ 12% vs 2022 (€ 1,013,538) Favourable step	€ 1,147,774 Total debts 2024: € 1,147,774 ▲ 29% vs 2023 (€ 892,588) Unfavourable step	€ 961,554 Total debts 2025: € 961,554 ▼ 16% vs 2024 (€ 1,147,774) Favourable step	▼ 16%
Cash	-	€ 2,997 Cash 2023: € 2,997 First fiscal year in the series	-	€ 1,592 Cash 2025: € 1,592 First fiscal year in the series
Land & buildings	€ 568,268 Land & buildings 2022: € 568,268 First fiscal year in the series	€ 502,054 Land & buildings 2023: € 502,054 ▼ 12% vs 2022 (€ 568,268) Unchanged	€ 440,838 Land & buildings 2024: € 440,838 ▼ 12% vs 2023 (€ 502,054) Unchanged	€ 395,252 Land & buildings 2025: € 395,252 ▼ 10% vs 2024 (€ 440,838) Unchanged	▼ 10%
Retained profit	€ 745,535 Retained profit 2022: € 745,535 First fiscal year in the series	€ 879,081 Retained profit 2023: € 879,081 ▲ 18% vs 2022 (€ 745,535) Favourable step	€ 422,110 Retained profit 2024: € 422,110 ▼ 52% vs 2023 (€ 879,081) Unfavourable step	€ 517,839 Retained profit 2025: € 517,839 ▲ 23% vs 2024 (€ 422,110) Favourable step	▲ 23%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 520,131 Dividend 2024: € 520,131 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 520,131) Unchanged	▼ 100%
Bank debt	€ 904,474 Bank debt 2022: € 904,474 First fiscal year in the series	€ 784,246 Bank debt 2023: € 784,246 ▼ 13% vs 2022 (€ 904,474) Favourable step	€ 821,132 Bank debt 2024: € 821,132 ▲ 5% vs 2023 (€ 784,246) Unfavourable step	€ 503,683 Bank debt 2025: € 503,683 ▼ 39% vs 2024 (€ 821,132) Favourable step	▼ 39%
Balance sheet total	€ 1,904,236 Balance sheet total 2022: € 1,904,236 First fiscal year in the series	€ 1,897,771 Balance sheet total 2023: € 1,897,771 Unchanged (€ 1,904,236) Unchanged	€ 1,679,777 Balance sheet total 2024: € 1,679,777 ▼ 11% vs 2023 (€ 1,897,771) Unchanged	€ 1,571,846 Balance sheet total 2025: € 1,571,846 ▼ 6% vs 2024 (€ 1,679,777) Unchanged	▼ 6%
Employees (FTE)	-	-	0.8 Employees (FTE) 2024: 0.8 First fiscal year in the series	0.8 Employees (FTE) 2025: 0.8 Unchanged (0.8) Unchanged

Key figures of Docteur Xavier NéLISSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Docteur Xavier NéLISSEN?

What happened at Docteur Xavier NéLISSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 95,729 (▲ 52% vs 2024). filed late Source: NBB ↗
May 1, 2025 New establishment in Liège. KBO
Oct 10, 2005 Start of the company according to the CBE. KBO
Oct 5, 2005 New establishment in Juprelle. KBO

In short

From € 121,103 profit in 2022 to € 95,729 profit in 2025.

Paid € 204,775 in corporate taxes since 2022.

Best year ever: 2023, with € 133,546 profit.

Paid out € 520,131 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Xavier Nélissen

Docteur Xavier NéLISSEN

Clinique du Mont Saint Martin

NELROH

PLASTIMMO

Behind Docteur Xavier NéLISSEN is Xavier Nélissen. Xavier Nélissen is also behind Clinique du Mont Saint Martin, NELROH, PLASTIMMO and XNconsulting.

Directors

According to the 2025 annual accounts

Xavier Nélissen

Director

Also active at: Clinique du Mont Saint Martin, NELROH, PLASTIMMO, XNconsulting

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Lambert Tilkin 2

4453 Juprelle

2.374.632.452

Rue Eugène-Ysaye 12 box A

4000 Liège

Active since 1 May 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0876.586.525
VAT number: BE 0876.586.525
Registered office: Rue Lambert Tilkin 2, 4453 Juprelle
Names & denominations: Docteur Xavier NéLISSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 October 2005
Peppol: Active · Active since 5 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗